Results of largest medical records-based analysis to date
Seven-pound tumor requires complex, multidisciplinary care
How a novel tissue marker makes a difference
Risk does not end after the acute phase is over.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study finds no evidence that dual coverage lowers risk of surgical site infection
The gastroenterologist's plans for the institute
The physician scientist discusses her vision for the program
Infliximab-abda offers similar benefits at lower costs
More accurate than existing noninvasive tests
A cost-effective alternative to enoxaparin?
Advertisement
Advertisement